 |
Granexin� gel (aCTI peptide) |
|---|---|
| Trade Name | |
| Orphan Indication | Cutaneous radiation injury due to radiation disaster |
| USA Market Approval | USA |
| USA Designation Date | 2017-08-03 00:00:00 |
| Sponsor | FirstString Research, Inc.;300 West Coleman Boulevard, Suite 203;Mount Pleasant, South Carolina, 29464 |
